Subsequent studies demonstrated that HIPK2 phosphorylates β-catenin for proteasomal degradation [49], thus interfering with the transcription of several β-catenin target genes, including vascular endothelial growth factor (VEGF) involved in tumor angiogenesis and tumor growth [50]. This evidence concerns the gene HIPK2 and neoplasm.